Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 5 | 2024 | 1103 | 1.740 |
Why?
|
| Computational Biology | 4 | 2024 | 293 | 1.480 |
Why?
|
| DNA Methylation | 2 | 2024 | 325 | 1.410 |
Why?
|
| Prognosis | 8 | 2024 | 739 | 1.290 |
Why?
|
| Genomics | 3 | 2020 | 223 | 1.250 |
Why?
|
| Lung Neoplasms | 3 | 2021 | 358 | 1.230 |
Why?
|
| MicroRNAs | 5 | 2023 | 426 | 1.160 |
Why?
|
| Sulfites | 2 | 2024 | 6 | 1.080 |
Why?
|
| Echocardiography | 4 | 2018 | 144 | 0.860 |
Why?
|
| Pulmonary Fibrosis | 1 | 2022 | 31 | 0.860 |
Why?
|
| Software | 1 | 2024 | 217 | 0.860 |
Why?
|
| Sequence Analysis, RNA | 3 | 2021 | 106 | 0.840 |
Why?
|
| Exosomes | 1 | 2023 | 101 | 0.830 |
Why?
|
| Transcription Factors | 2 | 2024 | 681 | 0.810 |
Why?
|
| Organ Specificity | 1 | 2020 | 129 | 0.740 |
Why?
|
| Immunotherapy | 1 | 2021 | 95 | 0.740 |
Why?
|
| Humans | 33 | 2024 | 37093 | 0.690 |
Why?
|
| Myocardial Perfusion Imaging | 2 | 2018 | 6 | 0.690 |
Why?
|
| Metabolome | 1 | 2019 | 53 | 0.690 |
Why?
|
| Research | 1 | 2020 | 163 | 0.680 |
Why?
|
| Phospholipids | 6 | 2021 | 70 | 0.660 |
Why?
|
| Lyases | 1 | 2019 | 51 | 0.660 |
Why?
|
| Amino Acids | 1 | 2019 | 145 | 0.660 |
Why?
|
| Sulfur Hexafluoride | 5 | 2018 | 5 | 0.510 |
Why?
|
| Thrombosis | 1 | 2015 | 63 | 0.490 |
Why?
|
| Aged | 13 | 2021 | 6741 | 0.480 |
Why?
|
| Contrast Media | 6 | 2018 | 92 | 0.470 |
Why?
|
| Mutation | 1 | 2019 | 1095 | 0.470 |
Why?
|
| Ultrasonography, Mammary | 4 | 2022 | 6 | 0.470 |
Why?
|
| Female | 24 | 2023 | 20969 | 0.450 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 441 | 0.450 |
Why?
|
| Predictive Value of Tests | 5 | 2021 | 400 | 0.450 |
Why?
|
| Breast Neoplasms | 5 | 2023 | 1502 | 0.450 |
Why?
|
| Biomedical Research | 1 | 2016 | 400 | 0.410 |
Why?
|
| Middle Aged | 13 | 2021 | 10129 | 0.400 |
Why?
|
| Male | 15 | 2021 | 20025 | 0.350 |
Why?
|
| Reproducibility of Results | 6 | 2020 | 935 | 0.340 |
Why?
|
| Chickens | 2 | 2021 | 133 | 0.330 |
Why?
|
| Aged, 80 and over | 8 | 2020 | 2379 | 0.330 |
Why?
|
| T-Lymphocytes | 2 | 2022 | 357 | 0.320 |
Why?
|
| Atherosclerosis | 2 | 2022 | 134 | 0.300 |
Why?
|
| Heart Neoplasms | 2 | 2018 | 7 | 0.300 |
Why?
|
| Sensitivity and Specificity | 6 | 2022 | 562 | 0.280 |
Why?
|
| Chromatin | 2 | 2024 | 169 | 0.270 |
Why?
|
| Image Enhancement | 2 | 2015 | 40 | 0.250 |
Why?
|
| Animals | 11 | 2022 | 15081 | 0.240 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 807 | 0.240 |
Why?
|
| Hemolysis | 1 | 2023 | 40 | 0.230 |
Why?
|
| Fasting | 1 | 2023 | 54 | 0.230 |
Why?
|
| Lymphatic Metastasis | 2 | 2022 | 65 | 0.230 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2024 | 58 | 0.230 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2023 | 34 | 0.220 |
Why?
|
| Renal Artery Obstruction | 1 | 2022 | 6 | 0.220 |
Why?
|
| Melanoma | 1 | 2024 | 96 | 0.220 |
Why?
|
| Metabolomics | 2 | 2021 | 81 | 0.210 |
Why?
|
| Methyltransferases | 1 | 2022 | 58 | 0.210 |
Why?
|
| Workflow | 1 | 2022 | 20 | 0.210 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 219 | 0.210 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 2021 | 10 | 0.210 |
Why?
|
| Fanconi Anemia | 1 | 2021 | 12 | 0.200 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 111 | 0.200 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 1 | 2021 | 9 | 0.200 |
Why?
|
| Adult | 10 | 2023 | 11712 | 0.200 |
Why?
|
| CpG Islands | 1 | 2022 | 97 | 0.200 |
Why?
|
| Colonic Neoplasms | 1 | 2024 | 186 | 0.200 |
Why?
|
| Endometrium | 1 | 2022 | 60 | 0.200 |
Why?
|
| Immunologic Factors | 1 | 2021 | 45 | 0.200 |
Why?
|
| Relaxin | 1 | 2021 | 10 | 0.200 |
Why?
|
| Mevalonic Acid | 1 | 2021 | 9 | 0.200 |
Why?
|
| Ethanolamine | 1 | 2021 | 8 | 0.190 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2020 | 9 | 0.190 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 78 | 0.190 |
Why?
|
| Meta-Analysis as Topic | 1 | 2020 | 30 | 0.190 |
Why?
|
| Up-Regulation | 2 | 2020 | 513 | 0.180 |
Why?
|
| Mixed Function Oxygenases | 1 | 2020 | 34 | 0.180 |
Why?
|
| Microarray Analysis | 1 | 2020 | 61 | 0.180 |
Why?
|
| RNA | 1 | 2022 | 241 | 0.180 |
Why?
|
| MAP Kinase Signaling System | 1 | 2022 | 169 | 0.180 |
Why?
|
| DNA Repair | 1 | 2021 | 188 | 0.180 |
Why?
|
| Neovascularization, Pathologic | 2 | 2013 | 127 | 0.180 |
Why?
|
| Mice, Knockout | 2 | 2021 | 933 | 0.180 |
Why?
|
| Databases, Genetic | 1 | 2020 | 93 | 0.180 |
Why?
|
| Teratogens | 1 | 2019 | 11 | 0.180 |
Why?
|
| Lung | 1 | 2022 | 446 | 0.170 |
Why?
|
| Norepinephrine | 2 | 2022 | 110 | 0.170 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2023 | 628 | 0.170 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2020 | 289 | 0.170 |
Why?
|
| Stomach Neoplasms | 1 | 2021 | 195 | 0.170 |
Why?
|
| Cytoskeletal Proteins | 1 | 2020 | 105 | 0.170 |
Why?
|
| Survival Analysis | 1 | 2020 | 325 | 0.170 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2019 | 61 | 0.170 |
Why?
|
| Mice | 5 | 2022 | 5913 | 0.170 |
Why?
|
| Diagnosis, Differential | 2 | 2020 | 217 | 0.170 |
Why?
|
| DNA Damage | 1 | 2021 | 352 | 0.170 |
Why?
|
| Cell Culture Techniques | 1 | 2019 | 142 | 0.170 |
Why?
|
| Membrane Proteins | 1 | 2022 | 517 | 0.170 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 190 | 0.170 |
Why?
|
| Egg Shell | 1 | 2018 | 10 | 0.160 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 213 | 0.160 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 113 | 0.160 |
Why?
|
| Prospective Studies | 5 | 2022 | 1378 | 0.160 |
Why?
|
| Selenoproteins | 1 | 2021 | 159 | 0.160 |
Why?
|
| Uterus | 1 | 2018 | 55 | 0.160 |
Why?
|
| Caenorhabditis elegans | 1 | 2019 | 78 | 0.160 |
Why?
|
| Risk Assessment | 2 | 2019 | 753 | 0.160 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 225 | 0.150 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 336 | 0.150 |
Why?
|
| Selenium | 1 | 2019 | 148 | 0.150 |
Why?
|
| Disease | 1 | 2016 | 18 | 0.140 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 539 | 0.140 |
Why?
|
| Signal Transduction | 3 | 2021 | 1908 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 643 | 0.130 |
Why?
|
| Observer Variation | 1 | 2015 | 52 | 0.130 |
Why?
|
| Heart Atria | 1 | 2015 | 26 | 0.130 |
Why?
|
| Arteries | 1 | 2015 | 65 | 0.120 |
Why?
|
| Ultrasonography | 4 | 2020 | 112 | 0.120 |
Why?
|
| Young Adult | 4 | 2020 | 4268 | 0.120 |
Why?
|
| Ventricular Function, Left | 1 | 2015 | 96 | 0.120 |
Why?
|
| Heart Ventricles | 1 | 2015 | 110 | 0.120 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 196 | 0.110 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2012 | 21 | 0.110 |
Why?
|
| Acute Coronary Syndrome | 1 | 2013 | 39 | 0.110 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2012 | 33 | 0.100 |
Why?
|
| Heart Defects, Congenital | 1 | 2012 | 60 | 0.100 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 142 | 0.100 |
Why?
|
| Embryo, Mammalian | 2 | 2022 | 153 | 0.100 |
Why?
|
| Oviposition | 2 | 2021 | 13 | 0.090 |
Why?
|
| Embryonic Development | 2 | 2021 | 76 | 0.090 |
Why?
|
| Carotid Stenosis | 1 | 2009 | 13 | 0.080 |
Why?
|
| Rabbits | 2 | 2022 | 283 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2021 | 286 | 0.080 |
Why?
|
| Adolescent | 2 | 2015 | 5363 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2023 | 626 | 0.070 |
Why?
|
| Child | 1 | 2015 | 3131 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2022 | 1207 | 0.070 |
Why?
|
| Retrospective Studies | 2 | 2020 | 2026 | 0.060 |
Why?
|
| Pancreas | 1 | 2023 | 35 | 0.060 |
Why?
|
| Kidney Cortex | 1 | 2022 | 8 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2023 | 70 | 0.050 |
Why?
|
| Genome, Viral | 1 | 2023 | 109 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2023 | 149 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2022 | 91 | 0.050 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2022 | 14 | 0.050 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2022 | 28 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2023 | 333 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 55 | 0.050 |
Why?
|
| Genomic Instability | 1 | 2021 | 38 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2022 | 74 | 0.050 |
Why?
|
| Eggs | 1 | 2021 | 7 | 0.050 |
Why?
|
| Oviducts | 1 | 2021 | 13 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2022 | 306 | 0.050 |
Why?
|
| Ethanolamines | 1 | 2021 | 12 | 0.050 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2021 | 21 | 0.050 |
Why?
|
| Lipogenesis | 1 | 2021 | 18 | 0.050 |
Why?
|
| Phosphatidylethanolamines | 1 | 2021 | 27 | 0.050 |
Why?
|
| Cattle | 1 | 2022 | 477 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2022 | 236 | 0.050 |
Why?
|
| DNA Replication | 1 | 2021 | 152 | 0.050 |
Why?
|
| Blastocyst | 1 | 2021 | 48 | 0.050 |
Why?
|
| Proteomics | 1 | 2023 | 325 | 0.050 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2021 | 67 | 0.050 |
Why?
|
| Glycolysis | 1 | 2021 | 68 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2021 | 90 | 0.050 |
Why?
|
| Cell Aggregation | 1 | 2019 | 15 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2019 | 67 | 0.040 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 145 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2022 | 1130 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2023 | 767 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 251 | 0.040 |
Why?
|
| Molting | 1 | 2018 | 8 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2019 | 208 | 0.040 |
Why?
|
| Bacteria | 1 | 2021 | 255 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 120 | 0.040 |
Why?
|
| Protein Binding | 1 | 2020 | 972 | 0.040 |
Why?
|
| Pregnancy | 1 | 2022 | 1549 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2018 | 435 | 0.040 |
Why?
|
| Algorithms | 1 | 2019 | 465 | 0.040 |
Why?
|
| Base Sequence | 1 | 2018 | 997 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2019 | 587 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2019 | 1518 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 1492 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 1609 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2021 | 1198 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 1371 | 0.030 |
Why?
|
| Models, Biological | 1 | 2018 | 677 | 0.030 |
Why?
|
| Aorta, Abdominal | 1 | 2014 | 9 | 0.030 |
Why?
|
| Reference Values | 1 | 2015 | 212 | 0.030 |
Why?
|
| China | 1 | 2015 | 196 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 173 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 225 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 441 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2009 | 117 | 0.020 |
Why?
|
| Risk Factors | 1 | 2013 | 3562 | 0.020 |
Why?
|